HemaCare Corporation

ABOUT HEMCARE: HemaCare, a Charles River company, is a global leader in the supply and customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development. Through our network of collection centers with access to an extensive recallable and reliable donor network, we provide clients with the cellular material they need for the development of the next generation of cell and gene therapies – including fresh and cryopreserved starting material and isolated cellular material derived from peripheral blood, bone marrow, and cord blood. Combined with Charles River’s integrated, early-stage portfolio of discovery, safety assessment, and manufacturing support services, we provide customers comprehensive solutions from discovery through commercialization. To learn more about our portfolio and services, visit www.hemacare.com. HEMACARE'S MISSION: Providing a best-in-class portfolio of high quality, customizable human cellular material and services to support drug discovery, scientific research, and cell therapy. HEMACARE'S VISION: Advancing drug discovery, scientific research, and cell therapy with the highest quality human cells. HemaCare is the trusted partner to some of the world’s leading pharmaceutical and biotech companies and research organizations. HemaCare has consistently provided high-quality cellular material for use in the process development for 100% of the currently commercially FDA-approved immunocellular therapies.